Grand River Aseptic Manufacturing (GRAM) is a contract development and manufacturing organization (CDMO) specializing in fill-finish of sterile injectables, including controlled substances. Founded in 2010, GRAM has grown consistently and quickly, and continues to invest in expansion of two Grand Rapids locations, best-in-class technology, and expertise to meet the growing demand for exceptional quality biologics and other parenterals. All equipment and processes are qualified and validated to ensure cGMP compliance, supported by analytical testing and regulatory expertise. In late 2017, Arlington Capital Partners invested in GRAM to become majority owner. This capital investment will fund ongoing expansion and capacity increases.